Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Women and Infants Hospital of Rhode Island
With
Ortho Biotech, Inc.
This study will evaluate the toxicities of Doxil and Gemcitabine given on an every two week basis. Our hypothesis is that toxicity will be less than that with standard dosing without any negative effect on survival. Patients will also be evaluated with CT scans every 3 months. Toxicity will be assessed with every cycle of treatment. Treatment will continue until toxicity or signs of progression.
